Checkmate 205 study results: nivolumab in classical Hodgkin Lymphoma

The Checkmate 205 study (NCT02181738) is looking at nivolumab in previously treated and newly diagnosed patients with classical Hodgkin lymphoma. Here, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, ... Author: VJHemOnc Added: 07/12/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts